|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000004804 breast cancer type 2 susceptibility protein |
BRCA2 |
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:F1P3B2 uncharacterized protein, BRCA2 translation product (chicken) |
chick-BRCA2 |
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:O35923 breast cancer type 2 susceptibility protein homolog (rat) |
rBRCA2 |
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P51587 breast cancer type 2 susceptibility protein (human) |
hBRCA2 |
Yes |
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060274 breast cancer type 2 susceptibility protein sequence variant Q1998* (human) |
hBRCA2/var:Q1998* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060282 breast cancer type 2 susceptibility protein sequence variant L1740* (human) |
hBRCA2/var:L1740* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060285 breast cancer type 2 susceptibility protein sequence variant S1968* (human) |
hBRCA2/var:S1968* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060333 breast cancer type 2 susceptibility protein sequence variant Q3066* (human) |
hBRCA2/var:Q3066* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060343 breast cancer type 2 susceptibility protein sequence variant Y1762* (human) |
hBRCA2/var:Y1762* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060354 breast cancer type 2 susceptibility protein sequence variant G1529E (human) |
hBRCA2/var:G1529E |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060390 breast cancer type 2 susceptibility protein sequence variant S3245* (human) |
hBRCA2/var:S3245* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060393 breast cancer type 2 susceptibility protein sequence variant E2906* (human) |
hBRCA2/var:E2906* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060421 breast cancer type 2 susceptibility protein sequence variant L2362* (human) |
hBRCA2/var:L2362* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060427 breast cancer type 2 susceptibility protein sequence variant E1120* (human) |
hBRCA2/var:E1120* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060466 breast cancer type 2 susceptibility protein sequence variant E3053* (human) |
hBRCA2/var:E3053* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060489 breast cancer type 2 susceptibility protein sequence variant K1860* (human) |
hBRCA2/var:K1860* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060516 breast cancer type 2 susceptibility protein sequence variant E865* (human) |
hBRCA2/var:E865* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060539 breast cancer type 2 susceptibility protein sequence variant G934* (human) |
hBRCA2/var:G934* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060549 breast cancer type 2 susceptibility protein sequence variant E2028* (human) |
hBRCA2/var:E2028* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060568 breast cancer type 2 susceptibility protein sequence variant Q2823* (human) |
hBRCA2/var:Q2823* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060571 breast cancer type 2 susceptibility protein sequence variant E97* (human) |
hBRCA2/var:E97* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060575 breast cancer type 2 susceptibility protein sequence variant L557* (human) |
hBRCA2/var:L557* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060602 breast cancer type 2 susceptibility protein sequence variant S2994* (human) |
hBRCA2/var:S2994* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060630 breast cancer type 2 susceptibility protein sequence variant Y803* (human) |
hBRCA2/var:Y803* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060653 breast cancer type 2 susceptibility protein sequence variant Q1562* (human) |
hBRCA2/var:Q1562* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060654 breast cancer type 2 susceptibility protein sequence variant S2095* (human) |
hBRCA2/var:S2095* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060677 breast cancer type 2 susceptibility protein sequence variant Y3006* (human) |
hBRCA2/var:Y3006* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060692 breast cancer type 2 susceptibility protein sequence variant L1208* (human) |
hBRCA2/var:L1208* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060763 breast cancer type 2 susceptibility protein sequence variant C711* (human) |
hBRCA2/var:C711* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060791 breast cancer type 2 susceptibility protein sequence variant C2422* (human) |
hBRCA2/var:C2422* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060829 breast cancer type 2 susceptibility protein sequence variant K2555* (human) |
hBRCA2/var:K2555* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060858 breast cancer type 2 susceptibility protein sequence variant S871* (human) |
hBRCA2/var:S871* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060887 breast cancer type 2 susceptibility protein sequence variant S1442* (human) |
hBRCA2/var:S1442* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060891 breast cancer type 2 susceptibility protein sequence variant W2626C (human) |
hBRCA2/var:W2626C |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060946 breast cancer type 2 susceptibility protein sequence variant Q499* (human) |
hBRCA2/var:Q499* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060956 breast cancer type 2 susceptibility protein sequence variant I2627F (human) |
hBRCA2/var:I2627F |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000060984 breast cancer type 2 susceptibility protein sequence variant S1013* (human) |
hBRCA2/var:S1013* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061047 breast cancer type 2 susceptibility protein sequence variant E1514* (human) |
hBRCA2/var:E1514* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061049 breast cancer type 2 susceptibility protein sequence variant W2970* (human) |
hBRCA2/var:W2970* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061057 breast cancer type 2 susceptibility protein sequence variant E2847* (human) |
hBRCA2/var:E2847* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061074 breast cancer type 2 susceptibility protein sequence variant Y1714* (human) |
hBRCA2/var:Y1714* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061081 breast cancer type 2 susceptibility protein sequence variant S1720* (human) |
hBRCA2/var:S1720* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061209 breast cancer type 2 susceptibility protein sequence variant E808* (human) |
hBRCA2/var:E808* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061227 breast cancer type 2 susceptibility protein sequence variant S1064* (human) |
hBRCA2/var:S1064* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061243 breast cancer type 2 susceptibility protein sequence variant S611* (human) |
hBRCA2/var:S611* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061248 breast cancer type 2 susceptibility protein sequence variant E2663Q (human) |
hBRCA2/var:E2663Q |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061249 breast cancer type 2 susceptibility protein sequence variant Q1175* (human) |
hBRCA2/var:Q1175* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061260 breast cancer type 2 susceptibility protein sequence variant S450* (human) |
hBRCA2/var:S450* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061267 breast cancer type 2 susceptibility protein sequence variant E475* (human) |
hBRCA2/var:E475* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061329 breast cancer type 2 susceptibility protein sequence variant S3231* (human) |
hBRCA2/var:S3231* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061343 breast cancer type 2 susceptibility protein sequence variant K1515* (human) |
hBRCA2/var:K1515* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061347 breast cancer type 2 susceptibility protein sequence variant W31* (human) |
hBRCA2/var:W31* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061354 breast cancer type 2 susceptibility protein sequence variant E1493* (human) |
hBRCA2/var:E1493* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061384 breast cancer type 2 susceptibility protein sequence variant M1300* (human) |
hBRCA2/var:M1300* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061413 breast cancer type 2 susceptibility protein sequence variant E2872* (human) |
hBRCA2/var:E2872* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061418 breast cancer type 2 susceptibility protein sequence variant Q73* (human) |
hBRCA2/var:Q73* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061434 breast cancer type 2 susceptibility protein sequence variant Q609* (human) |
hBRCA2/var:Q609* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061436 breast cancer type 2 susceptibility protein sequence variant E1688* (human) |
hBRCA2/var:E1688* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061439 breast cancer type 2 susceptibility protein sequence variant S76* (human) |
hBRCA2/var:S76* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061442 breast cancer type 2 susceptibility protein sequence variant L2926* (human) |
hBRCA2/var:L2926* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061485 breast cancer type 2 susceptibility protein sequence variant C1200* (human) |
hBRCA2/var:C1200* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061491 breast cancer type 2 susceptibility protein sequence variant Y2997* (human) |
hBRCA2/var:Y2997* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061572 breast cancer type 2 susceptibility protein sequence variant K230* (human) |
hBRCA2/var:K230* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061616 breast cancer type 2 susceptibility protein sequence variant Q893* (human) |
hBRCA2/var:Q893* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061622 breast cancer type 2 susceptibility protein sequence variant K3015* (human) |
hBRCA2/var:K3015* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061675 breast cancer type 2 susceptibility protein sequence variant S2052* (human) |
hBRCA2/var:S2052* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061755 breast cancer type 2 susceptibility protein sequence variant K1082* (human) |
hBRCA2/var:K1082* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061760 breast cancer type 2 susceptibility protein sequence variant Q1452* (human) |
hBRCA2/var:Q1452* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061763 breast cancer type 2 susceptibility protein sequence variant G904* (human) |
hBRCA2/var:G904* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061772 breast cancer type 2 susceptibility protein sequence variant I1258* (human) |
hBRCA2/var:I1258* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061793 breast cancer type 2 susceptibility protein sequence variant S1099* (human) |
hBRCA2/var:S1099* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061829 breast cancer type 2 susceptibility protein sequence variant K2392* (human) |
hBRCA2/var:K2392* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061844 breast cancer type 2 susceptibility protein sequence variant V323* (human) |
hBRCA2/var:V323* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061867 breast cancer type 2 susceptibility protein sequence variant S2372* (human) |
hBRCA2/var:S2372* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061909 breast cancer type 2 susceptibility protein sequence variant R2659T (human) |
hBRCA2/var:R2659T |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061914 breast cancer type 2 susceptibility protein sequence variant E866* (human) |
hBRCA2/var:E866* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061921 breast cancer type 2 susceptibility protein sequence variant E1717* (human) |
hBRCA2/var:E1717* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061926 breast cancer type 2 susceptibility protein sequence variant Y2977* (human) |
hBRCA2/var:Y2977* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061932 breast cancer type 2 susceptibility protein sequence variant E2474* (human) |
hBRCA2/var:E2474* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061964 breast cancer type 2 susceptibility protein sequence variant E1812* (human) |
hBRCA2/var:E1812* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000061987 breast cancer type 2 susceptibility protein sequence variant Q1063* (human) |
hBRCA2/var:Q1063* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062045 breast cancer type 2 susceptibility protein sequence variant E1593* (human) |
hBRCA2/var:E1593* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062063 breast cancer type 2 susceptibility protein sequence variant K1649* (human) |
hBRCA2/var:K1649* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062082 breast cancer type 2 susceptibility protein sequence variant E3111* (human) |
hBRCA2/var:E3111* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062110 breast cancer type 2 susceptibility protein sequence variant L638* (human) |
hBRCA2/var:L638* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062124 breast cancer type 2 susceptibility protein sequence variant E409* (human) |
hBRCA2/var:E409* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062133 breast cancer type 2 susceptibility protein sequence variant E510* (human) |
hBRCA2/var:E510* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062147 breast cancer type 2 susceptibility protein sequence variant G2837* (human) |
hBRCA2/var:G2837* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062152 breast cancer type 2 susceptibility protein sequence variant S353* (human) |
hBRCA2/var:S353* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062206 breast cancer type 2 susceptibility protein sequence variant T2722R (human) |
hBRCA2/var:T2722R |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062240 breast cancer type 2 susceptibility protein sequence variant Q754* (human) |
hBRCA2/var:Q754* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062314 breast cancer type 2 susceptibility protein sequence variant L2375* (human) |
hBRCA2/var:L2375* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062320 breast cancer type 2 susceptibility protein sequence variant W2586* (human) |
hBRCA2/var:W2586* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062322 breast cancer type 2 susceptibility protein sequence variant D2723H (human) |
hBRCA2/var:D2723H |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062340 breast cancer type 2 susceptibility protein sequence variant M2393* (human) |
hBRCA2/var:M2393* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062357 breast cancer type 2 susceptibility protein sequence variant Q2024* (human) |
hBRCA2/var:Q2024* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062427 breast cancer type 2 susceptibility protein sequence variant Q1429* (human) |
hBRCA2/var:Q1429* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062479 breast cancer type 2 susceptibility protein sequence variant M965* (human) |
hBRCA2/var:M965* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062484 breast cancer type 2 susceptibility protein sequence variant L1776* (human) |
hBRCA2/var:L1776* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062501 breast cancer type 2 susceptibility protein sequence variant Q373* (human) |
hBRCA2/var:Q373* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062546 breast cancer type 2 susceptibility protein sequence variant E2956* (human) |
hBRCA2/var:E2956* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062558 breast cancer type 2 susceptibility protein sequence variant R2625* (human) |
hBRCA2/var:R2625* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062573 breast cancer type 2 susceptibility protein sequence variant S1271* (human) |
hBRCA2/var:S1271* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062574 breast cancer type 2 susceptibility protein sequence variant Q3036* (human) |
hBRCA2/var:Q3036* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062635 breast cancer type 2 susceptibility protein sequence variant E654* (human) |
hBRCA2/var:E654* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062704 breast cancer type 2 susceptibility protein sequence variant G2281* (human) |
hBRCA2/var:G2281* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062708 breast cancer type 2 susceptibility protein sequence variant G25V (human) |
hBRCA2/var:G25V |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062756 breast cancer type 2 susceptibility protein sequence variant T2722I (human) |
hBRCA2/var:T2722I |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062761 breast cancer type 2 susceptibility protein sequence variant E1646* (human) |
hBRCA2/var:E1646* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062820 breast cancer type 2 susceptibility protein sequence variant E826* (human) |
hBRCA2/var:E826* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062834 breast cancer type 2 susceptibility protein sequence variant K1872* (human) |
hBRCA2/var:K1872* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062861 breast cancer type 2 susceptibility protein sequence variant Q2870* (human) |
hBRCA2/var:Q2870* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062866 breast cancer type 2 susceptibility protein sequence variant E2863* (human) |
hBRCA2/var:E2863* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062900 breast cancer type 2 susceptibility protein sequence variant Y2884* (human) |
hBRCA2/var:Y2884* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062904 breast cancer type 2 susceptibility protein sequence variant S744* (human) |
hBRCA2/var:S744* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062918 breast cancer type 2 susceptibility protein sequence variant K2570* (human) |
hBRCA2/var:K2570* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062947 breast cancer type 2 susceptibility protein sequence variant Q1987* (human) |
hBRCA2/var:Q1987* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062976 breast cancer type 2 susceptibility protein sequence variant L2696* (human) |
hBRCA2/var:L2696* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062987 breast cancer type 2 susceptibility protein sequence variant Y1894* (human) |
hBRCA2/var:Y1894* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000062990 breast cancer type 2 susceptibility protein sequence variant G1529R (human) |
hBRCA2/var:G1529R |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063010 breast cancer type 2 susceptibility protein sequence variant E2959* (human) |
hBRCA2/var:E2959* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063042 breast cancer type 2 susceptibility protein sequence variant S2695* (human) |
hBRCA2/var:S2695* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063067 breast cancer type 2 susceptibility protein sequence variant E1285* (human) |
hBRCA2/var:E1285* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063072 breast cancer type 2 susceptibility protein sequence variant G1006* (human) |
hBRCA2/var:G1006* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063079 breast cancer type 2 susceptibility protein sequence variant S3291A (human) |
hBRCA2/var:S3291A |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063108 breast cancer type 2 susceptibility protein sequence variant L553* (human) |
hBRCA2/var:L553* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063120 breast cancer type 2 susceptibility protein sequence variant Q1124* (human) |
hBRCA2/var:Q1124* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063123 breast cancer type 2 susceptibility protein sequence variant S2835* (human) |
hBRCA2/var:S2835* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063206 breast cancer type 2 susceptibility protein sequence variant R3128* (human) |
hBRCA2/var:R3128* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063222 breast cancer type 2 susceptibility protein sequence variant G2593* (human) |
hBRCA2/var:G2593* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063225 breast cancer type 2 susceptibility protein sequence variant F1182* (human) |
hBRCA2/var:F1182* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063240 breast cancer type 2 susceptibility protein sequence variant E3071* (human) |
hBRCA2/var:E3071* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063243 breast cancer type 2 susceptibility protein sequence variant G25R (human) |
hBRCA2/var:G25R |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063256 breast cancer type 2 susceptibility protein sequence variant R2520* (human) |
hBRCA2/var:R2520* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063262 breast cancer type 2 susceptibility protein sequence variant W31R (human) |
hBRCA2/var:W31R |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063272 breast cancer type 2 susceptibility protein sequence variant E1276* (human) |
hBRCA2/var:E1276* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063289 breast cancer type 2 susceptibility protein sequence variant E294* (human) |
hBRCA2/var:E294* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063290 breast cancer type 2 susceptibility protein sequence variant R2401* (human) |
hBRCA2/var:R2401* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063301 breast cancer type 2 susceptibility protein sequence variant G561* (human) |
hBRCA2/var:G561* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063320 breast cancer type 2 susceptibility protein sequence variant E1581* (human) |
hBRCA2/var:E1581* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063327 breast cancer type 2 susceptibility protein sequence variant E2663V (human) |
hBRCA2/var:E2663V |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063385 breast cancer type 2 susceptibility protein sequence variant E2129* (human) |
hBRCA2/var:E2129* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063387 breast cancer type 2 susceptibility protein sequence variant G995* (human) |
hBRCA2/var:G995* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063389 breast cancer type 2 susceptibility protein sequence variant K604* (human) |
hBRCA2/var:K604* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063404 breast cancer type 2 susceptibility protein sequence variant E2476* (human) |
hBRCA2/var:E2476* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063407 breast cancer type 2 susceptibility protein sequence variant Q1658* (human) |
hBRCA2/var:Q1658* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063423 breast cancer type 2 susceptibility protein sequence variant E1113* (human) |
hBRCA2/var:E1113* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063424 breast cancer type 2 susceptibility protein sequence variant G2748D (human) |
hBRCA2/var:G2748D |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063448 breast cancer type 2 susceptibility protein sequence variant W2626L (human) |
hBRCA2/var:W2626L |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063456 breast cancer type 2 susceptibility protein sequence variant Q2159* (human) |
hBRCA2/var:Q2159* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063497 breast cancer type 2 susceptibility protein sequence variant R2318* (human) |
hBRCA2/var:R2318* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063540 breast cancer type 2 susceptibility protein sequence variant E897* (human) |
hBRCA2/var:E897* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063561 breast cancer type 2 susceptibility protein sequence variant E1518* (human) |
hBRCA2/var:E1518* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063585 breast cancer type 2 susceptibility protein sequence variant Q1551* (human) |
hBRCA2/var:Q1551* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063657 breast cancer type 2 susceptibility protein sequence variant L105* (human) |
hBRCA2/var:L105* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063667 breast cancer type 2 susceptibility protein sequence variant E1555* (human) |
hBRCA2/var:E1555* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063673 breast cancer type 2 susceptibility protein sequence variant Q2354* (human) |
hBRCA2/var:Q2354* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063689 breast cancer type 2 susceptibility protein sequence variant S2978* (human) |
hBRCA2/var:S2978* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063713 breast cancer type 2 susceptibility protein sequence variant G1122* (human) |
hBRCA2/var:G1122* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063737 breast cancer type 2 susceptibility protein sequence variant K1453* (human) |
hBRCA2/var:K1453* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063759 breast cancer type 2 susceptibility protein sequence variant E305* (human) |
hBRCA2/var:E305* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063762 breast cancer type 2 susceptibility protein sequence variant L1952* (human) |
hBRCA2/var:L1952* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063781 breast cancer type 2 susceptibility protein sequence variant G4* (human) |
hBRCA2/var:G4* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063901 breast cancer type 2 susceptibility protein sequence variant S1630* (human) |
hBRCA2/var:S1630* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063952 breast cancer type 2 susceptibility protein sequence variant S1882* (human) |
hBRCA2/var:S1882* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000063961 breast cancer type 2 susceptibility protein sequence variant Q2749* (human) |
hBRCA2/var:Q2749* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064047 breast cancer type 2 susceptibility protein sequence variant Q3026* (human) |
hBRCA2/var:Q3026* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064081 breast cancer type 2 susceptibility protein sequence variant K467* (human) |
hBRCA2/var:K467* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064088 breast cancer type 2 susceptibility protein sequence variant E2599* (human) |
hBRCA2/var:E2599* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064098 breast cancer type 2 susceptibility protein sequence variant E1441* (human) |
hBRCA2/var:E1441* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064128 breast cancer type 2 susceptibility protein sequence variant E880* (human) |
hBRCA2/var:E880* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064169 breast cancer type 2 susceptibility protein sequence variant G106* (human) |
hBRCA2/var:G106* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064172 breast cancer type 2 susceptibility protein sequence variant V1862* (human) |
hBRCA2/var:V1862* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064320 breast cancer type 2 susceptibility protein sequence variant K944* (human) |
hBRCA2/var:K944* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064380 breast cancer type 2 susceptibility protein sequence variant L2428* (human) |
hBRCA2/var:L2428* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064389 breast cancer type 2 susceptibility protein sequence variant E2571* (human) |
hBRCA2/var:E2571* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064410 breast cancer type 2 susceptibility protein sequence variant L659* (human) |
hBRCA2/var:L659* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064420 breast cancer type 2 susceptibility protein sequence variant E187* (human) |
hBRCA2/var:E187* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064423 breast cancer type 2 susceptibility protein sequence variant Q2731* (human) |
hBRCA2/var:Q2731* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064473 breast cancer type 2 susceptibility protein sequence variant K178* (human) |
hBRCA2/var:K178* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064511 breast cancer type 2 susceptibility protein sequence variant K3032* (human) |
hBRCA2/var:K3032* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064536 breast cancer type 2 susceptibility protein sequence variant S1385* (human) |
hBRCA2/var:S1385* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064549 breast cancer type 2 susceptibility protein sequence variant W31C (human) |
hBRCA2/var:W31C |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064558 breast cancer type 2 susceptibility protein sequence variant S648* (human) |
hBRCA2/var:S648* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064571 breast cancer type 2 susceptibility protein sequence variant G405* (human) |
hBRCA2/var:G405* |
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:000064582 breast cancer type 2 susceptibility protein sequence variant D2723G (human) |
hBRCA2/var:D2723G |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000035486 breast cancer type 2 susceptibility protein phosphorylated 1 (human) |
hBRCA2/Phos:1 |
Yes |
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000045544 breast cancer type 2 susceptibility protein phosphorylated 2 (human) |
hBRCA2/Phos:2 |
Yes |
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000045545 breast cancer type 2 susceptibility protein unphosphorylated 2 (human) |
hBRCA2/UnPhos:2 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000045817 breast cancer type 2 susceptibility protein phosphorylated 3 (human) |
hBRCA2/Phos:3 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000066432 breast cancer type 2 susceptibility protein deaminated 1 (human) |
hBRCA2/Deam:1 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000066492 breast cancer type 2 susceptibility protein deaminated 2 (human) |
hBRCA2/Deam:2 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000067955 breast cancer type 2 susceptibility protein methylated 1 (human) |
hBRCA2/Me:1 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000070934 breast cancer type 2 susceptibility protein methylated 2 (human) |
hBRCA2/Me:2 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000072027 breast cancer type 2 susceptibility protein deaminated 3 (human) |
hBRCA2/Deam:3 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000072752 breast cancer type 2 susceptibility protein methylated 3 (human) |
hBRCA2/Me:3 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000073005 breast cancer type 2 susceptibility protein deaminated 4 (human) |
hBRCA2/Deam:4 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000075561 breast cancer type 2 susceptibility protein phosphorylated 4 (human) |
hBRCA2/Phos:4 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000078580 breast cancer type 2 susceptibility protein cysteinylated 1 (human) |
hBRCA2/Cyst:1 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000080574 breast cancer type 2 susceptibility protein methylated 4 (human) |
hBRCA2/Me:4 |
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P97929 breast cancer type 2 susceptibility protein homolog (mouse) |
mBRCA2 |
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q54BU8 uncharacterized protein, DDB_G0293414 translation product (Dictyostelium discoideum) |
Dicty-BRCA2 |
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000035485 breast cancer type 2 susceptibility protein phosphorylated 1 |
BRCA2/Phos:1 |
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000035486 breast cancer type 2 susceptibility protein phosphorylated 1 (human) |
hBRCA2/Phos:1 |
Yes |
|
|
|
